Committed Capital

Committed Capital is a UK-based investor offering tax-efficient EIS and venture investment vehicles for accredited and high-net-worth investors, focused on backing British growth companies across technology, consumer, and healthcare. The firm’s structure — anchored in the Enterprise Investment Scheme regime — gives them a tax-driven LP base and a preference for British-incorporated companies that fit EIS criteria. Healthcare exposure is real but selective, with deals across digital health, healthcare services, and selective medtech where the company is UK-based and EIS-eligible. Stage focus is typically Series A and later seed, with check sizes plausibly GBP 500K to 3M per deal and capacity to syndicate larger rounds across multiple EIS-qualifying clients. For healthcare AI founders, Committed Capital is most relevant if you are a UK-incorporated company with revenue traction, a clear path to profitability, and a willingness to operate within EIS-related compliance and reporting. Founders who should approach: UK healthcare AI businesses with traction, particularly those serving NHS trusts, private insurers, or UK employers, where the EIS structure is genuinely useful and the team is comfortable with the tax-compliance overhead. Founders who should not approach: US-incorporated companies, pre-revenue science-heavy plays, and teams that find EIS compliance and reporting requirements disproportionate to the capital. Their value-add is a steady stream of EIS-aligned capital, UK operating relationships, and a long history of supporting British growth-stage businesses. Entry path is warm introduction through UK corporate finance advisors, accountants, or portfolio CEOs. Their website and LinkedIn page accept inbound submissions. Be prepared to discuss EIS eligibility — qualifying-trade tests and gross-asset thresholds — early in the conversation.